All Episodes
Oncotarget — 500 episodes · page 2 of 5
Cigarette Smoke and DNA Repair Deficiency Drive Lung Cancer Development
Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model
Targeting PCNA-Androgen Receptor Interaction Suppresses Prostate Cancer Cell Growth
Blocking PRDX1 Protein May Improve Chemotherapy Response in Ovarian Cancer
Immune Side Effects of Liver Cancer Therapy Studied in Latin American Patients
Engineered Proteins Show Promise in Stopping Glioblastoma Invasion
Combining Radiation and Immunotherapy Shows Promise for Bladder Cancer
New Ultra-Sensitive DNA Blood Test for Detecting Residual Cancer in B-cell Lymphoma Patients
Blood Type A Identified as Potential Breast Cancer Risk Factor
METTL3 Drives Oral Cancer by Blocking Tumor-Suppressing Gene
Panitumumab & Low-Dose Capecitabine: Promising Maintenance Therapy for Metastatic Colorectal Cancer
Oncotarget Participation at SSP 2025 Annual Meeting
Early Immune Evasion Found in HPV-Related Pre-Cancer Lesions of the Anogenital Region
New Insights into p53: A Powerful Gene’s Role in Cancer Therapy
Gene Variant Linked to Benign Prostate Hyperplasia Risk in Lebanese Men
Protein GSK3β Offers New Angle on Overcoming Melanoma Drug Resistance
Targeting SETDB1: A New Strategy for Treating Osteosarcoma
AI That Measures Its Own Uncertainty Could Improve Liver Cancer Detection
Triple Therapy Slows Glioblastoma Growth and Extends Survival in Preclinical Study
Single Protein Mimics Retinoic Acid Therapy to Help Leukemia Cells Mature
NSD2 Gene Drives Cancer Cell Identity in Multiple Myeloma
When the Cure Becomes the Cause: A Rare Case of Cancer from Donor Cells
Why Some Breast Cancer Treatments Stop Working
Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes
WIN Consortium Leading the Future of Precision Cancer Medicine
Oncotarget to Participate at the AACR Annual Meeting 2025
A Rare Genetic Shift That Helped Lung Cancer Evade Treatment
Rethinking Breast Cancer Screening: New Insights on Overdiagnosis
How Environmental Exposures Affect Genes and Increase Cancer Risk
Engineered TIMP Molecules Show Potential to Slow Glioblastoma Brain Cancer Spread
How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success
Researchers Identify New p53 Targets to Combat Cancer Growth
Innovative Biomaterial Accelerates Healing of Chemotherapy-Induced Oral Ulcers in Animal Model
Panitumumab with Low-Dose Capecitabine as a Maintenance Regimen: A Viable Option?
SETDB1 Amplification Identified as a Potential Target for New Osteosarcoma Treatment
HER2-Low Breast Cancer: A New Understanding
Rare Case of Donor Cell-Derived Blood Cancer Discovered Nine Years After Stem Cell Transplant
New Genetic Mutation Linked to Drug Resistance in Non-Small Cell Lung Cancer Patient
A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1
Tracking cfDNA Release Dynamics During Colorectal Cancer Surgery
HER2-Low Breast Cancer: Genomic Insights and Evolving Treatment Paradigms
Anti-Correlation Between KLRG1 and PD-1 in Tumor CD8 T Cells
Mastocytosis: Key Insights into KIT M541L Gene Mutation
The Hidden Risks of At-Home Genetic Cancer Tests
Pitfalls of FDA-Approved Germline Cancer Predisposition Tests
A New Path to Tumor Suppression: The Promise of PG3
Breakthroughs in Cell-Penetrating Monoclonal Antibody Therapies
CT Radiomics and Body Composition for Predicting Hepatic Decompensation
Small Cell Lung Cancer: Advancing Precision Medicine with Biomarker Research
B7-H4 as a Therapeutic Target in Adenoid Cystic Carcinoma
Mesenchymal Stem Cells in Cancer Immunotherapy: Promises and Challenges
Persistence Landscapes: A Path to Unbiased Radiological Interpretation
Visualizing Radiological Data Bias with Persistence Images
Persistence Barcodes: Reducing Bias in Radiological Analysis
Behind the Study: DLL3, ASC1, TTF-1 & Ki-67 in Precision Medicine for SCLC
Reducing Bias in Radiology with Topological Data Analysis
Cancer Dormancy and Tumor Recurrence: New Insights for Breast Cancer
Extracellular Matrix and Tumor-Immune Interactions: Challenges & Opportunities
Navigating Bias in AI-Driven Cancer Detection
Precision Medicine in SCLC: DLL3, ASC1, TTF-1, and Ki-67 Expression
Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer
Tumor Dormancy Initiated by Lymphovascular Embolus
Complete Response to Encorafenib + Binimetinib in BRAF V600E-Mutant Tumor
Behind the Study: Molecular Chaperones & Tumor Suppressor Stability
Next-Generation Antibodies for Cancer Therapy
How Blood Cancer Cells Rewire to Evade Drug Treatment
Tribute to Dr. Mikhail (Misha) Blagosklonny
Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition
Molecular Chaperones: Guardians of Tumor Suppressor Stability
TP53 Mutated AML: Transplant or No Transplant
Targeting Stem Cell-like Traits: How miR-10b Inhibition Treats Metastatic Breast Cancer
Zika Virus as a Treatment for Brain Cancer: A Systematic Review
Lessons from ACDC-RP Trial: Designing Neoadjuvant Therapy Trials for Prostatectomy
Key Roles of MIF, DDT, and CD74 in Melanoma Prognosis and Therapy
miR-10b Inhibition: A Strategy for Treating Metastatic Breast Cancer
Artificial Intelligence: Revolutionizing Precision Oncology
Genotype Matters: Tailored Screening for Germline CHEK2 Variants
Disrupting NKG2A:HLA-E Interactions for Enhanced Anti-Cancer Immunity
Role of the Gut Barrier in Colorectal Cancer Treatment
Nanobody Inhibits Metastasis of Breast Tumor Cells to Lung in Mice
Response of BRAF-Mutated Spindle Cell Sarcoma to BRAF/MEK Inhibitors
New Directions in Targeting the Multifaceted BRAF in Cancer
Combining Regorafenib and TAS102 to Target Gastrointestinal Cancers and Overcome Cancer Stemness
TCR CDR3s and Renalase-1 Linked to Increased Melanoma Survival
Dealing with Runaway Metastatic Disease
INT-1B3 miR-193a-3p Mimic Boosts T Cell Immunity and Induces Tumor Cell Death
Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma
Novel Triple-Drug Combination to Fight Pancreatic Cancer
Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis
Oncotarget Welcomes New Editorial Board Members
Efficacy of Pembrolizumab with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
DDX41’s Unique Contribution to Myeloid Leukemogenesis
Using Early On-treatment ctDNA Measurements as Response Assessment in mCRPC
HER2-low and HER2-zero in Breast Cancer Between Prognosis, Prediction and Entity
Comparison of FDG-PET/CT and CT for Treatment Evaluation of Patients With Unresectable Mesothelioma
AI for Improved PET/CT Attenuation Correction in Prostate Cancer Imaging
Targeting ABC Transporters in PDAC – Past, Present, or Future?
Regorafenib Synergizes With TAS102 Against Multiple Gastrointestinal Cancers
Editorial: Genomics Has More to Reveal
Starving Cancer Cells to Enhance DNA Damage and Immunotherapy Response